M Fernandez-Chas1, M J Curtis1, S A Niederer1. 1. Division of Imaging Sciences and Biomedical Engineering (MF, SAN) and Cardiovascular Division (MJC), King's College London, London, UK.
Abstract
BACKGROUND AND PURPOSE: Doxorubicin (DOX) is an effective cancer therapeutic agent but causes therapy-limiting cardiotoxicity. The effects of DOX and its metabolite doxorubicinol (DOXL) on individual channels have been well characterized in isolation. However, it is unknown how the action and interaction of affected channels combine to generate the phenotypic cardiotoxic outcome. We sought to develop an in silico model that links drug effects on channels to action potential duration (APD) and intracellular Ca2+ concentration in order to address this gap in knowledge. EXPERIMENTAL APPROACH: We first propose two methods to obtain, from published values, consensus drug effects on the currents of individual channels, transporters and pumps. Separately, we obtained equivalent values for APD and Ca2+ concentration (the readouts used as surrogates for cardiotoxicity). Once derived, the consensus effects on the currents were incorporated into established biophysical models of the cardiac myocyte and were refined adjusting the sarcoplasmic reticulum Ca2+ leak current (ILeak ) until the consensus effects on APD and Ca2+ dynamics were replicated. Using factorial analysis, we then quantified the relative contribution of each channel to DOX and DOXL cardiotoxicity. KEY RESULTS: The factorial analysis identified the rapid delayed rectifying K+ current, the L-type Ca2+ current and the sarcoplasmic reticulum ILeak as the targets primarily responsible for the cardiotoxic effects on APD and Ca2+ dynamics. CONCLUSIONS AND IMPLICATIONS: This study provides insight into the mechanisms of DOX-induced cardiotoxicity and a framework for the development of future diagnostic and therapeutic strategies.
BACKGROUND AND PURPOSE: Doxorubicin (DOX) is an effective cancer therapeutic agent but causes therapy-limiting cardiotoxicity. The effects of DOX and its metabolite doxorubicinol (DOXL) on individual channels have been well characterized in isolation. However, it is unknown how the action and interaction of affected channels combine to generate the phenotypic cardiotoxic outcome. We sought to develop an in silico model that links drug effects on channels to action potential duration (APD) and intracellular Ca2+ concentration in order to address this gap in knowledge. EXPERIMENTAL APPROACH: We first propose two methods to obtain, from published values, consensus drug effects on the currents of individual channels, transporters and pumps. Separately, we obtained equivalent values for APD and Ca2+ concentration (the readouts used as surrogates for cardiotoxicity). Once derived, the consensus effects on the currents were incorporated into established biophysical models of the cardiac myocyte and were refined adjusting the sarcoplasmic reticulum Ca2+ leak current (ILeak ) until the consensus effects on APD and Ca2+ dynamics were replicated. Using factorial analysis, we then quantified the relative contribution of each channel to DOX and DOXL cardiotoxicity. KEY RESULTS: The factorial analysis identified the rapid delayed rectifying K+ current, the L-type Ca2+ current and the sarcoplasmic reticulum ILeak as the targets primarily responsible for the cardiotoxic effects on APD and Ca2+ dynamics. CONCLUSIONS AND IMPLICATIONS: This study provides insight into the mechanisms of DOX-induced cardiotoxicity and a framework for the development of future diagnostic and therapeutic strategies.
Authors: Martin Fink; Steven A Niederer; Elizabeth M Cherry; Flavio H Fenton; Jussi T Koivumäki; Gunnar Seemann; Rüdiger Thul; Henggui Zhang; Frank B Sachse; Dan Beard; Edmund J Crampin; Nicolas P Smith Journal: Prog Biophys Mol Biol Date: 2010-03-18 Impact factor: 3.667
Authors: Nathalie Selevsek; Florian Caiment; Ramona Nudischer; Hans Gmuender; Irina Agarkova; Francis L Atkinson; Ivo Bachmann; Vanessa Baier; Gal Barel; Chris Bauer; Stefan Boerno; Nicolas Bosc; Olivia Clayton; Henrik Cordes; Sally Deeb; Stefano Gotta; Patrick Guye; Anne Hersey; Fiona M I Hunter; Laura Kunz; Alex Lewalle; Matthias Lienhard; Jort Merken; Jasmine Minguet; Bernardo Oliveira; Carla Pluess; Ugis Sarkans; Yannick Schrooders; Johannes Schuchhardt; Ines Smit; Christoph Thiel; Bernd Timmermann; Marcha Verheijen; Timo Wittenberger; Witold Wolski; Alexandra Zerck; Stephane Heymans; Lars Kuepfer; Adrian Roth; Ralph Schlapbach; Steven Niederer; Ralf Herwig; Jos Kleinjans Journal: Commun Biol Date: 2020-10-15
Authors: Kevin J Lee; Griffin Wright; Hannah Bryant; Leigh Ann Wiggins; Valeria L Dal Zotto; Michele Schuler; Christopher Malozzi; Michael V Cohen; Natalie R Gassman Journal: Int J Mol Sci Date: 2021-07-12 Impact factor: 5.923